Profil
Donald G.
Comb is the founder of New England Biolabs GmbH and New England Biolabs, Inc. He held the title of Chairman at New England Biolabs, Inc. from 1974 to 2020.
He also worked as a Director at New England Biolabs (UK) Ltd.
Anciens postes connus de Donald G. Comb
| Sociétés | Poste | Fin |
|---|---|---|
New England Biolabs, Inc.
 New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries New England Biolabs, Inc. produces and supplies reagents for the life science industry. The firm?s products include restriction endonucleases, PCR, qPCR and amplification technologies, DNA modifying enzymes, sample preparation for next generation sequencing, nucleic acid purification, DNA assembly, cloning and mutagenesis kits, genome editing, competent cells, markers and ladders, RNA reagents, gene expression, cellular analysis, epigenetics, protein tools, DNA plasmids, glycobiology, protein expression and purification technologies. The company was founded by Donald Comb in 1974 and is headquartered in Ipswich, MA. | Fondateur | 01/01/2020 |
New England Biolabs (UK) Ltd.
 New England Biolabs (UK) Ltd. Medical SpecialtiesHealth Technology Part of New England Biolabs, Inc., New England Biolabs (UK) Ltd. is a British company that provides molecular biology reagents and technical support. The company is based in Hitchin, UK. The company offers a range of products including restriction enzymes, polymerases, competent cells, and sample prep for NGS. Additionally, they provide endoglycosidases, exoglycosidases, and heparinases for glycobiology research. Founded in 1993, James V. Ellard has been the CEO of the company since 1984. | Directeur/Membre du Conseil | 01/01/2020 |
New England Biolabs GmbH
 New England Biolabs GmbH BiotechnologyHealth Technology Part of New England Biolabs, Inc., New England Biolabs GmbH develops molecular biology reagents. The company is based in Frankfurt am Main, Germany. The German company was founded in 1974 by Donald G. Comb, Richard Roberts. The CEO is Thomas Möllenkamp. | Fondateur | 01/01/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
New England Biolabs, Inc.
New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries New England Biolabs, Inc. produces and supplies reagents for the life science industry. The firm?s products include restriction endonucleases, PCR, qPCR and amplification technologies, DNA modifying enzymes, sample preparation for next generation sequencing, nucleic acid purification, DNA assembly, cloning and mutagenesis kits, genome editing, competent cells, markers and ladders, RNA reagents, gene expression, cellular analysis, epigenetics, protein tools, DNA plasmids, glycobiology, protein expression and purification technologies. The company was founded by Donald Comb in 1974 and is headquartered in Ipswich, MA. | Process Industries |
New England Biolabs GmbH
New England Biolabs GmbH BiotechnologyHealth Technology Part of New England Biolabs, Inc., New England Biolabs GmbH develops molecular biology reagents. The company is based in Frankfurt am Main, Germany. The German company was founded in 1974 by Donald G. Comb, Richard Roberts. The CEO is Thomas Möllenkamp. | Health Technology |
New England Biolabs (UK) Ltd.
New England Biolabs (UK) Ltd. Medical SpecialtiesHealth Technology Part of New England Biolabs, Inc., New England Biolabs (UK) Ltd. is a British company that provides molecular biology reagents and technical support. The company is based in Hitchin, UK. The company offers a range of products including restriction enzymes, polymerases, competent cells, and sample prep for NGS. Additionally, they provide endoglycosidases, exoglycosidases, and heparinases for glycobiology research. Founded in 1993, James V. Ellard has been the CEO of the company since 1984. | Health Technology |
